Chris Wolski and Prasanth Perugupalli, chief product officer for Pramana, tackle why there have been delays in pathology labs adopting digital solutions, the business case for digital pathology, how it can change laboratory workflows, and what the future holds for digital pathology.
Researchers at SANKEN, Osaka University have demonstrated a method of releasing DNA at the point of measurement.
The BioChromato C10 Smart Evaporator offers a productive sample preparation tool for labs tasked with solvent removal directly from liquid chromatography vials or concentration of multiple samples from extraction or fractionation processes.
Shenzhen Superbio Technology received FDA clearance for its point-of-care instrument intended for the detection of fentanyl in human urine.
Bio-Rad’s new StarBright Dyes will be available to Cytek to develop and commercialize reagent products on cytometry systems.
This technology could become a reality within a few years, and contains a key component called the whispering gallery mode microresonator.
U.S. Healthcare professionals can access a new novel NAD+ blood diagnostic test for their patients, following the new partnership.
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
InBios has been granted the U.S. Food and Drug Administration’s (FDA) first marketing rights for an anthrax point-of-care (POC) test.